Inovio Pharmaceuticals Inc (INO)

[jfkspire]

Awesome post:Inovio Hopes to See Strong Results in Human Trials
After its vaccine candidate demonstrated strong animal study results, Inovio Pharmaceuticals now hopes to see solid success in human trials, as well. So far, the company has enrolled 40 healthy volunteers in Phase 1 trials, and expects to post preliminary data by late June 2020.

Patients will receive two doses of the vaccine four weeks apart. If results are as solid as the animal studies, it may be able to move to Phase 2/3 trials by summer, pending approval. The company is also in Phase 1/2 human trials for the vaccine in South Korea after receiving $6.9 million in funding from the Coalition of Epidemic Preparedness (CEPI).

It’s also working with Beijing Advaccine Biotechnology to create a vaccine in China, as well. In fact, according to the company, “Inovio will leverage Advaccine’s expertise to conduct a Phase 1 trial in China in parallel with Inovio’s clinical development efforts in the U.S. and South Korea.”

Better, the trials are well funded. To date, CEPI has awarded Inovio more than $17.2 million, according to the company. The Department of Defense also gave it and Ology Bioservices $11.9 million for rapid production of the Inovio vaccine. The Bill & Melinda Gates Foundation also backed Inovio with a $5 million grant to accelerate testing.
https://investorplace.com/2020/05/inovio-shows-plenty-of-promise-outside-of-the-coronavirus/amp/


Inovio has more Global Exposure!! & In S.Korea it will be approved after just 2Phases!!